Table of Content

1. Product Overview
2. Research Methodology
3. Impact of COVID-19 on Global Gynecology Drugs Market
4. Executive Summary
5. Voice of Customer
5.1. Brand Awareness
5.2. Factors Influencing Purchase Decision of the Drug
5.3. Patient Satisfaction Analysis
6. Global Gynecology Drugs Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Therapeutics (Hormonal Therapy vs. Non-Hormonal Therapy)
6.2.2. By Indication (Gynecology Cancers, Polycystic Ovary Syndrome, Contraception, Endometriosis, Female Infertility, Gynecology Infections, Postmenopausal Disorders)
6.2.3. By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)
6.2.4. By Company (2020)
6.2.5. By Region (North America, Europe, Asia-Pacific, South America, Middle East & Africa)
6.3. Product Market Map
7. North America Gynecology Drugs Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Therapeutics
7.2.2. By Indication
7.2.3. By Distribution Channel
7.2.4. By Country (United States; Canada; Mexico)
7.3. North America: Country Analysis
7.3.1. United States Gynecology Drugs Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Therapeutics
7.3.1.2.2. By Indication
7.3.1.2.3. By Distribution Channel
7.3.2. Canada Gynecology Drugs Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Therapeutics
7.3.2.2.2. By Indication
7.3.2.2.3. By Distribution Channel
7.3.3. Mexico Gynecology Drugs Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Therapeutics
7.3.3.2.2. By Indication
7.3.3.2.3. By Distribution Channel
8. Europe Gynecology Drugs Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Therapeutics
8.2.2. By Indication
8.2.3. By Distribution Channel
8.2.4. By Country (Germany; France; United Kingdom; Italy; Spain)
8.3. Europe: Country Analysis
8.3.1. Germany Gynecology Drugs Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Therapeutics
8.3.1.2.2. By Indication
8.3.1.2.3. By Distribution Channel
8.3.2. France Gynecology Drugs Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Therapeutics
8.3.2.2.2. By Indication
8.3.2.2.3. By Distribution Channel
8.3.3. United Kingdom Gynecology Drugs Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Therapeutics
8.3.3.2.2. By Indication
8.3.3.2.3. By Distribution Channel
8.3.4. Italy Gynecology Drugs Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Therapeutics
8.3.4.2.2. By Indication
8.3.4.2.3. By Distribution Channel
8.3.5. Spain Gynecology Drugs Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Therapeutics
8.3.5.2.2. By Indication
8.3.5.2.3. By Distribution Channel
9. Asia-Pacific Gynecology Drugs Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Therapeutics
9.2.2. By Indication
9.2.3. By Distribution Channel
9.2.4. By Country (China; Japan; India; Australia; South Korea)
9.3. Asia Pacific: Country Analysis
9.3.1. China Gynecology Drugs Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Therapeutics
9.3.1.2.2. By Indication
9.3.1.2.3. By Distribution Channel
9.3.2. Japan Gynecology Drugs Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Therapeutics
9.3.2.2.2. By Indication
9.3.2.2.3. By Distribution Channel
9.3.3. India Gynecology Drugs Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Therapeutics
9.3.3.2.2. By Indication
9.3.3.2.3. By Distribution Channel
9.3.4. Australia Gynecology Drugs Market Outlook
9.3.4.1. Market Size & Forecast
9.3.4.1.1. By Value
9.3.4.2. Market Share & Forecast
9.3.4.2.1. By Therapeutics
9.3.4.2.2. By Indication
9.3.4.2.3. By Distribution Channel
9.3.5. South Korea Gynecology Drugs Market Outlook
9.3.5.1. Market Size & Forecast
9.3.5.1.1. By Value
9.3.5.2. Market Share & Forecast
9.3.5.2.1. By Therapeutics
9.3.5.2.2. By Indication
9.3.5.2.3. By Distribution Channel
10. South America Gynecology Drugs Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Therapeutics
10.2.2. By Indication
10.2.3. By Distribution Channel
10.2.4. By Country (Brazil; Argentina; Colombia)
10.3. South America: Country Analysis
10.3.1. Brazil Gynecology Drugs Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Therapeutics
10.3.1.2.2. By Indication
10.3.1.2.3. By Distribution Channel
10.3.2. Argentina Gynecology Drugs Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Therapeutics
10.3.2.2.2. By Indication
10.3.2.2.3. By Distribution Channel
10.3.3. Colombia Gynecology Drugs Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Therapeutics
10.3.3.2.2. By Indication
10.3.3.2.3. By Distribution Channel
11. Middle East and Africa Gynecology Drugs Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Therapeutics
11.2.2. By Indication
11.2.3. By Distribution Channel
11.2.4. By Country (South Africa; Saudi Arabia ; UAE)
11.3. MEA: Country Analysis
11.3.1. South Africa Gynecology Drugs Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Therapeutics
11.3.1.2.2. By Indication
11.3.1.2.3. By Distribution Channel
11.3.2. Saudi Arabia Gynecology Drugs Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Therapeutics
11.3.2.2.2. By Indication
11.3.2.2.3. By Distribution Channel
11.3.3. UAE Gynecology Drugs Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Therapeutics
11.3.3.2.2. By Indication
11.3.3.2.3. By Distribution Channel
12. Market Dynamics
12.1. Drivers
12.2. Challenges
13. Market Trends & Developments
14. Competitive Landscape
14.1. Competition Outlook
14.2. Global Players Profiled (Leading Companies)
14.2.1. Amgen Inc.
14.2.2. F. Hoffmann-La Roche Ltd.
14.2.3. Novartis Ltd.
14.2.4. Bayer AG
14.2.5. Merck & Co., Inc.
14.2.6. GlaxoSmithKline Plc
14.2.7. Sanofi SA
14.2.8. Eli Lilly and Company Ltd.
14.2.9. Ferring Pharmaceuticals A/S
14.2.10. AstraZeneca Plc
14.2.11. TherapeuticsMD, Inc.
14.2.12. AbbVie Inc.
14.2.13. Abbott Laboratories Ltd.
14.2.14. Lupin Pharmaceuticals, Inc.
14.2.15. Pfizer Inc.
15. Strategic Recommendations
16. About Us & Disclaimer



List of Figures

Figure 1: Global Gynecology Drugs Market Size, By Value (USD Million), 2016-2026F
Figure 2: Global Gynecology Drugs Market Share, By Therapeutics, By Value, 2016-2026F
Figure 3: Global Gynecology Drugs Market Share, By Indication, By Value, 2016-2026F
Figure 4: Global Gynecology Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 5: Global Gynecology Drugs Market Share, By Company, By Value, 2020
Figure 6: Global Gynecology Drugs Market Share, By Region, By Value, 2016-2026F
Figure 7: Global Gynecology Drugs Product Market Map, By Value, 2016-2026F
Figure 8: North America Gynecology Drugs Market Size, By Value (USD Million), 2016-2026F
Figure 9: North America Gynecology Drugs Market Share, By Therapeutics, By Value, 2016-2026F
Figure 10: North America Gynecology Drugs Market Share, By Indication, By Value, 2016-2026F
Figure 11: North America Gynecology Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 12: North America Gynecology Drugs Market Share, By Country, By Value, 2016-2026F
Figure 13: United States Gynecology Drugs Market Size, By Value (USD Million), 2016-2026F
Figure 14: United States Gynecology Drugs Market Share, By Therapeutics, By Value, 2016-2026F
Figure 15: United States Gynecology Drugs Market Share, By Indication, By Value, 2016-2026F
Figure 16: United States Gynecology Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 17: Canada Gynecology Drugs Market Size, By Value (USD Million), 2016-2026F
Figure 18: Canada Gynecology Drugs Market Share, By Therapeutics, By Value, 2016-2026F
Figure 19: Canada Gynecology Drugs Market Share, By Indication, By Value, 2016-2026F
Figure 20: Canada Gynecology Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 21: Mexico Gynecology Drugs Market Size, By Value (USD Million), 2016-2026F
Figure 22: Mexico Gynecology Drugs Market Share, By Therapeutics, By Value, 2016-2026F
Figure 23: Mexico Gynecology Drugs Market Share, By Indication, By Value, 2016-2026F
Figure 24: Mexico Gynecology Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 25: Europe Gynecology Drugs Market Size, By Value (USD Million), 2016-2026F
Figure 26: Europe Gynecology Drugs Market Share, By Therapeutics, By Value, 2016-2026F
Figure 27: Europe Gynecology Drugs Market Share, By Indication, By Value, 2016-2026F
Figure 28: Europe Gynecology Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 29: Europe Gynecology Drugs Market Share, By Country, By Value, 2016-2026F
Figure 30: Germany Gynecology Drugs Market Size, By Value (USD Million), 2016-2026F
Figure 31: Germany Gynecology Drugs Market Share, By Therapeutics, By Value, 2016-2026F
Figure 32: Germany Gynecology Drugs Market Share, By Indication, By Value, 2016-2026F
Figure 33: Germany Gynecology Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 34: France Gynecology Drugs Market Size, By Value (USD Million), 2016-2026F
Figure 35: France Gynecology Drugs Market Share, By Therapeutics, By Value, 2016-2026F
Figure 36: France Gynecology Drugs Market Share, By Indication, By Value, 2016-2026F
Figure 37: France Gynecology Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 38: United Kingdom Gynecology Drugs Market Size, By Value (USD Million), 2016-2026F
Figure 39: United Kingdom Gynecology Drugs Market Share, By Therapeutics, By Value, 2016-2026F
Figure 40: United Kingdom Gynecology Drugs Market Share, By Indication, By Value, 2016-2026F
Figure 41: United Kingdom Gynecology Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 42: Italy Gynecology Drugs Market Size, By Value (USD Million), 2016-2026F
Figure 43: Italy Gynecology Drugs Market Share, By Therapeutics, By Value, 2016-2026F
Figure 44: Italy Gynecology Drugs Market Share, By Indication, By Value, 2016-2026F
Figure 45: Italy Gynecology Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 46: Spain Gynecology Drugs Market Size, By Value (USD Million), 2016-2026F
Figure 47: Spain Gynecology Drugs Market Share, By Therapeutics, By Value, 2016-2026F
Figure 48: Spain Gynecology Drugs Market Share, By Indication, By Value, 2016-2026F
Figure 49: Spain Gynecology Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 50: APAC Gynecology Drugs Market Size, By Value (USD Million), 2016-2026F
Figure 51: APAC Gynecology Drugs Market Share, By Therapeutics, By Value, 2016-2026F
Figure 52: APAC Gynecology Drugs Market Share, By Indication, By Value, 2016-2026F
Figure 53: APAC Gynecology Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 54: APAC Gynecology Drugs Market Share, By Country, By Value, 2016-2026F
Figure 55: China Gynecology Drugs Market Size, By Value (USD Million), 2016-2026F
Figure 56: China Gynecology Drugs Market Share, By Therapeutics, By Value, 2016-2026F
Figure 57: China Gynecology Drugs Market Share, By Indication, By Value, 2016-2026F
Figure 58: China Gynecology Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 59: Japan Gynecology Drugs Market Size, By Value (USD Million), 2016-2026F
Figure 60: Japan Gynecology Drugs Market Share, By Therapeutics, By Value, 2016-2026F
Figure 61: Japan Gynecology Drugs Market Share, By Indication, By Value, 2016-2026F
Figure 62: Japan Gynecology Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 63: India Gynecology Drugs Market Size, By Value (USD Million), 2016-2026F
Figure 64: India Gynecology Drugs Market Share, By Therapeutics, By Value, 2016-2026F
Figure 65: India Gynecology Drugs Market Share, By Indication, By Value, 2016-2026F
Figure 66: India Gynecology Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 67: Australia Gynecology Drugs Market Size, By Value (USD Million), 2016-2026F
Figure 68: Australia Gynecology Drugs Market Share, By Therapeutics, By Value, 2016-2026F
Figure 69: Australia Gynecology Drugs Market Share, By Indication, By Value, 2016-2026F
Figure 70: Australia Gynecology Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 71: South Korea Gynecology Drugs Market Size, By Value (USD Million), 2016-2026F
Figure 72: South Korea Gynecology Drugs Market Share, By Therapeutics, By Value, 2016-2026F
Figure 73: South Korea Gynecology Drugs Market Share, By Indication, By Value, 2016-2026F
Figure 74: South Korea Gynecology Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 75: South America Gynecology Drugs Market Size, By Value (USD Million), 2016-2026F
Figure 76: South America Gynecology Drugs Market Share, By Therapeutics, By Value, 2016-2026F
Figure 77: South America Gynecology Drugs Market Share, By Indication, By Value, 2016-2026F
Figure 78: South America Gynecology Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 79: South America Gynecology Drugs Market Share, By Country, By Value, 2016-2026F
Figure 80: Brazil Gynecology Drugs Market Size, By Value (USD Million), 2016-2026F
Figure 81: Brazil Gynecology Drugs Market Share, By Therapeutics, By Value, 2016-2026F
Figure 82: Brazil Gynecology Drugs Market Share, By Indication, By Value, 2016-2026F
Figure 83: Brazil Gynecology Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 84: Argentina Gynecology Drugs Market Size, By Value (USD Million), 2016-2026F
Figure 85: Argentina Gynecology Drugs Market Share, By Therapeutics, By Value, 2016-2026F
Figure 86: Argentina Gynecology Drugs Market Share, By Indication, By Value, 2016-2026F
Figure 87: Argentina Gynecology Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 88: Colombia Gynecology Drugs Market Size, By Value (USD Million), 2016-2026F
Figure 89: Colombia Gynecology Drugs Market Share, By Therapeutics, By Value, 2016-2026F
Figure 90: Colombia Gynecology Drugs Market Share, By Indication, By Value, 2016-2026F
Figure 91: Colombia Gynecology Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 92: MEA Gynecology Drugs Market Size, By Value (USD Million), 2016-2026F
Figure 93: MEA Gynecology Drugs Market Share, By Therapeutics, By Value, 2016-2026F
Figure 94: MEA Gynecology Drugs Market Share, By Indication, By Value, 2016-2026F
Figure 95: MEA Gynecology Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 96: MEA Gynecology Drugs Market Share, By Country, By Value, 2016-2026F
Figure 97: South Africa Gynecology Drugs Market Size, By Value (USD Million), 2016-2026F
Figure 98: South Africa Gynecology Drugs Market Share, By Therapeutics, By Value, 2016-2026F
Figure 99: South Africa Gynecology Drugs Market Share, By Indication, By Value, 2016-2026F
Figure 100: South Africa Gynecology Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 101: Saudi Arabia Gynecology Drugs Market Size, By Value (USD Million), 2016-2026F
Figure 102: Saudi Arabia Gynecology Drugs Market Share, By Therapeutics, By Value, 2016-2026F
Figure 103: Saudi Arabia Gynecology Drugs Market Share, By Indication, By Value, 2016-2026F
Figure 104: Saudi Arabia Gynecology Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 105: UAE Gynecology Drugs Market Size, By Value (USD Million), 2016-2026F
Figure 106: UAE Gynecology Drugs Market Share, By Therapeutics, By Value, 2016-2026F
Figure 107: UAE Gynecology Drugs Market Share, By Indication, By Value, 2016-2026F
Figure 108: UAE Gynecology Drugs Market Share, By Distribution Channel, By Value, 2016-2026F